JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scales, B.
Right arrow Articles by McIntosh, D. A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scales, B.
Right arrow Articles by McIntosh, D. A. D.
Journal of Pharmacology And Experimental Therapeutics, Vol. 160, Issue 2, 261-267, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


EFFECTS OF PROPRANOLOL AND ITS OPTICAL ISOMERS ON THE RADIOCALCIUM UPTAKE AND THE ADENOSINE TRIPHOSPHATASES OF SKELETAL AND CARDIAC SARCOPLASMIC RETICULUM FRACTIONS (SRF)

B. Scales 1 and D. A. D. McIntosh 1

1 Imperial Chemical Industries Ltd., Pharmaceuticals Division, Alderley Park, Macclesfield, Cheshire, England

The effects of the beta adrenergic blocking drugs, propranolol, pronethalol, MJ-1999 and N-isopropyl-p-nitrophenylethanolamine (INPEA), on the Ca++ uptake and the adenosine triphosphatases (ATPases) of skeletal and cardiac sarcoplasmic reticulum fractions (SRF) have been investigated. All produced an inhibition of the Ca++ uptake of skeletal and cardiac SRF. The degree of inhibition at any one concentration decreased in the order: (±)-propranolol and its isomers, (±)-pronethalol, INPEA and MJ-1999. With the exception of the dextro isomer of propranolol, this order correlates approximately with their ability to antagonize the ventricular arrhythmias and the chronotropic and inotropic responses of cardiac muscle produced by catecholamines. The ability of these beta adrenergic blocking agents to inhibit cyclic 3', 5'-adenosine monophosphate (3', 5'-AMP)-stimulated glycogenolysis and lipolysis may be related to their modification of Ca++ transport across the membranes.

Submitted on March 30, 1967
Accepted on December 18, 1967




This article has been cited by other articles:


Home page
ScienceHome page
M. Morad
Contracture and Catecholamines in Mammalian Myocardium
Science, October 24, 1969; 166(3904): 505 - 506.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.